Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 TrialYan Zhao, Jianzhong Zhang, Xiao‐Yong Man et al.|Advances in Therapy|2025Cited by 3
Stapokibart Rapidly and Consistently Improves the Clinical Signs Across All Body Regions in Adults With Moderate‐to‐Severe Atopic DermatitisYan Zhao, Jianzhong Zhang, Litao Zhang et al.|International Journal of Dermatology|2025Cited by 2
Guidelines for the diagnosis and treatment of prurigo nodularisLi Zhang, Xing‐Hua Gao, Qingchun Diao et al.|Chinese Medical Journal|2025Cited by 2
OEM China Metal Chassis Fabrication Factory - ZengritYicen Yan, Hang Li, Hui Chen et al.|Unknown|2020Cited by 0
Wholesale China Redundant Access Controller Factory - YunkeYicen Yan, Hang Li, Hui Chen et al.|Unknown|2020Cited by 0